Daiichi Sankyo announced that the first patient has been dosed in the global phase 3 TROPION-Lung17 trial. The study is ...
Discover how precision lung cancer care tackles gene fusions, new HER2/ROS1/ALK drugs, expanded screening, and liquid ...
As a nonsmoker lung cancer hasn't been a concern of mine, but I recently heard it can affect people who have never smoked. If ...
The trust that runs the major hospitals in Shropshire is taking part in a new lung cancer study to find alternative ...
Abenacianine, a fluorescent imaging agent, received FDA fast track status for enhancing tumor visualization during lung cancer surgery, showing safety and efficacy in phase 2 trials. Alecensa ...
SurvivorNet on MSN
Bayer’s Dr. Dominik Ruettinger on a promising new oral treatment option for patients with HER2+ lung cancer
A targeted therapy called sevabertinib has been approved for patients with non-small cell lung cancer that carries an ...
Cancer survival might depend on what time of day you get your treatment, a new study says. Lung cancer patients who received IV immunotherapy doses earlier in the day tended to live longer, ...
Radiation therapy is a cornerstone of lung cancer treatment. But even when delivered with precision, radiation can damage ...
As is often the case with cancer treatments, many patients are able to benefit from therapy for a time. Tumor activity ...
Immunotherapy is a cancer treatment that harnesses the body’s immune system to fight cancer. It helps the immune system recognize and attack cancer cells, which can sometimes be hidden from the body’s ...
Modelling indicates that over a 20-year period, a national screening programme could detect around 9,000 lung cancers and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results